Thermo Scientific B·R·A·H·M·S Biomarkers investigates, develops and manufactures novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With high-quality immunodiagnostic tests for prenatal screening, cardiovascular, pulmonary, and cancer disorders as well as particularly for sepsis, the company contributes to the creation of a healthier future – to the greatest advantage for medical professionals and patients.
On the basis of completely owned patents and with help of more than 500 employees worldwide, Thermo Scientific B·R·A·H·M·S Biomarkers is leading in specific market places and therapeutic areas. The aim of the basic research is to identify new biomarkers, with support by international co-operations and reputable research institutions.